Caprock Group’s AEON Biopharma AEON Stock Holding History

Caprock Group’s Portfolio AEON Stock Details AEON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-871	Closed	-$33.9K	–	1077
2024 Q4	$33.9K	Hold	871	–	–	﹤0.01%	986
2024 Q3	$65.8K	Buy	+871	New	+$76.7K	﹤0.01%	882

Other funds holding AEON

DIG

Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

DCM

Dupont Capital Management Wilmington, Delaware $2.18M AUM 50.81% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

Caprock Group's AEON Position: Q1 2025 in Review

Caprock Group sold out of AEON Biopharma (AEON) in Q1 2025, closing a stake of 871 shares — an estimated $33.9K sold.

Caprock Group first reported a position in AEON in Q3 2024 and held it in 2 quarters. The position peaked at $65.8K in Q3 2024. 16 funds tracked by Wall St. Rank hold AEON as of Q1 2025.

Caprock Group reported no remaining AEON Biopharma position as of Q1 2025 after selling out during the quarter.
Caprock Group sold 871 AEON Biopharma shares in Q1 2025, an estimated $33.9K.
Caprock Group first reported a position in AEON Biopharma in Q3 2024 and held it in 2 quarters.
Caprock Group's AEON Biopharma position peaked at $65.8K in Q3 2024.
16 funds tracked by Wall St. Rank held AEON Biopharma as of Q1 2025.

Based on Caprock Group's 13F filing for Q1 2025, filed 15 May 2025.